Abeona Therapeutics Inc (NASDAQ: ABEO) stock closed at $5.72 on 9/15/25 after a major decline of -11.0%. Moreover, trading volume in this decline was exceptionally high at 307% of normal. The stock has been strong relative to the market over the last nine months but has declined -16.9% during the last week.
Current PriceTarget Research Rating
Abeona Therapeutics has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Abeona Therapeutics has a very low Appreciation Score of 1 but a slightly positive Power Rating of 68, leading to the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment